IntegReview IRB
IntegReview is a fully accredited IRB responsible for providing protection to human research subjects in the pharmaceutical industry since 1999.
10/29/2020
10/22/2020
FDA Approves First Treatment for COVID-19 FDA approved Veklury (remdesivir) for adults and pediatric patients 12 years of age and older for the treatment of COVID-19 requiring hospitalization
10/16/2020
A year ago, the cystic fibrosis community celebrated the approval of Trikafta, a highly effective CFTR modulator for individuals who have at least one copy of the F508del mutation. Join us on Facebook Live Thursday, October 22 at 1 p.m. ET for plenary two of NACFC led by Jennifer Taylor-Cousar, MD, MSc, to learn about the amazing progress in our understanding of the benefits of highly effective CFTR modulators.
Click here to claim your Sponsored Listing.
Contact the school
Telephone
Website
Address
3815 S Capital Of Texas Highway, Ste 320
Austin, TX
78704
Opening Hours
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |